# PROMISS Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/promiss-diagnostics

- Industry: Healthcare Specialists
- Headquarters: Wauwatosa, US
- Website: www.promissdx.com
- Total disclosed funding: $0.4M
- Latest round: Seed (Sep 17, 2019)
- Investors on record: 2

## About

Based in Wisconsin, US, and founded in 2017 by Chief Executive Officer Jalal Sulaiman, Promiss Diagnostics, Inc. operates as a biotechnology-based company providing diagnostic equipment and testing to diagnose the ovarian cancers. In September 2019, PROMISS Diagnostics, Inc. raised USD 0.40 million in seed funding led by WARF Ventures, with participation from Cream City Venture Capital. 

Promiss Diagnostics, Inc.  developed a diagnostic test known as Promiss (Predicting Risk of Ovarian Malignancy in Serum Samples), which is a machine learning-based clinical diagnostic test for ovarian cancer. The company’s test records parameters in a structured manner with an algorithm to give a score which indicates the presence of ovarian cancer. In addition, the firm focuses on deducting cancer at early stage of the female reproductive system to improve survival rate.

## Funding rounds

- Seed, Sep 17, 2019, $0.4M — Cream City Venture Capital, WARF Ventures

## Investors

- Cream City Venture Capital (https://capitalatlas.ai/funds/cream-city-venture-capital) — Seed
- WARF Ventures (https://capitalatlas.ai/funds/warf-ventures) — Seed